tirzepatide latest news FDA approves new version of diabetes drug Mounjaro to be sold for weight loss As promised, here are the

We dont know what kind of hair loss was reported (e.g., telogen effluvium, androgenic alopecia, alopecia areata) or whether the hair loss was clinically diagnosed or self-reported by the user

The efficacy regarding lowering glycemia and body weight is stronger than that of GLP-1RAs while the safety profile and the incidence of adverse events seem comparable

Safety matters: nausea is common, while pancreatitis, gallbladder problems, and thyroid tumor warnings need attention

[Significance of melatonin in malignant diseases]

Seventy percent ethanol extract was provided at doses of 300, 600 and 1200 mg/kg to genetically obese in Zucker rats resulting in a reduction of circulating GLP-1 by acting on GLP-1 receptors [32]